Join
Live feed
·
INSIDERFilingvia Quantisnow
Nurix Therapeutics Inc. logo

Chief Scientific Officer Hansen Gwenn converted options into 8,608 shares and sold $53,498 worth of shares (3,214 units at $16.65), increasing direct ownership by 5% to 120,399 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRIX (Nurix Therapeutics Inc.) and more on Quantisnow.